GILD

Gilead Sciences

Halal Rating :
Uncomfortable
See Details
Last Price $73.30 Last updated:
Market Cap $93.38b
7D Change -0.08%
1 Year Change 18.84%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing
Exchange NASDAQ
Next Earnings Date Oct. 26, 2023

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
June 30, 2023 $6.42b $4.09b - $230m 0.00% 5.62%
March 31, 2023 $6.12b $3.79b - $230m 0.00% 6.06%
Dec. 31, 2022 $7.16b $4.23b - $226m 0.00% 5.35%

Company Impact

Help us evaluate Gilead Sciences's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Justification for our Halal Rating

Contribute

Recent News & Updates